People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Other, Other Technology, Manufacturing, Biotechnology, Sports & Fitness
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Renascence Equity Ventures, Inc. | — | Other | Series D+ | $400.0M | $6.1B | 2021 |
| Impinj Inc | — | Other Technology | Series B | $27.4M | $659.3M | 2010 |
| HaloSource Inc | — | Manufacturing | Series B | $22.9M | $10.8M | 2018 |
| Kotura Inc | — | Other Technology | Series A | $4.7M | $130.1M | 2009 |
| Ticketleap Inc | — | Other Technology | Seed | $4.0M | $23.0M | 2009 |
| OpenBench, Inc. | — | Other Technology | Seed | $2.7M | $39.1M | 2020 |
| Bo Jackson's Elite Sports-Hilliard, LLC | — | Other | Seed | $2.0M | $37.2M | 2016 |
| Grannus Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $1.8M | $5.4M | 2022 |
| Bo Jackson'S Elite Sports-Bensenville Llc | — | Sports & Fitness | Seed | $1.6M | $29.7M | 2018 |
JAMES THOMPSON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JAMES THOMPSON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| G. Scott Greenburg | 1 | 35 |
| Clinton Bybee | 1 | 10 |
| Cliff Higgerson | 1 | 6 |
| Kent Johnson | 1 | 6 |
| TOM ALBERG | 1 | 4 |
| Stephen Arnold | 1 | 4 |
| COLIN EVANS | 1 | 4 |
| CHRISTOPHER STANCHAK | 1 | 3 |
| MICHAEL ARONSON | 1 | 3 |
| ALAN MATTHEWS | 1 | 3 |
| Bradley Feld | 1 | 3 |
| Kent L Johnson | 1 | 2 |
| Craig Crowell | 1 | 2 |
| Gregory Sessler | 1 | 2 |
| Albert Yu | 1 | 2 |
| S. PETER ALBERT | 1 | 2 |
| Vincent Jackson | 1 | 2 |
| Jean-Louis Malinge | 1 | 2 |
| Tingye Li | 1 | 2 |
| Wayne L Keast | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.